|
US2956926A
(en)
*
|
1958-09-23 |
1960-10-18 |
American Cyanamid Co |
Coated citric acid particles
|
|
NZ196348A
(en)
*
|
1980-03-07 |
1984-08-24 |
Interx Research Corp |
Enhancement of absorption rate of orally administered antibiotics
|
|
JPS57146723A
(en)
*
|
1981-03-06 |
1982-09-10 |
Toyo Jozo Co Ltd |
Pharmaceutical preparation having improved absorption
|
|
US4537772A
(en)
*
|
1984-05-02 |
1985-08-27 |
Merck & Co., Inc. |
Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
|
|
US5789234A
(en)
|
1987-08-14 |
1998-08-04 |
Unigene Laboratories, Inc. |
Expression systems for amidating enzyme
|
|
US5912014A
(en)
|
1996-03-15 |
1999-06-15 |
Unigene Laboratories, Inc. |
Oral salmon calcitonin pharmaceutical products
|
|
ATE484572T1
(de)
|
1997-04-16 |
2010-10-15 |
Unigene Lab Inc |
Direkte expression von peptiden ins kulturmedium
|
|
EP1251867A4
(en)
|
2000-02-04 |
2004-12-08 |
Unigene Lab Inc |
NASAL CALCITON INFORMATION
|
|
US6673574B2
(en)
|
2000-11-30 |
2004-01-06 |
Unigene Laboratories Inc. |
Oral delivery of peptides using enzyme-cleavable membrane translocators
|
|
US7316819B2
(en)
|
2001-03-08 |
2008-01-08 |
Unigene Laboratories, Inc. |
Oral peptide pharmaceutical dosage form and method of production
|
|
US6890918B2
(en)
*
|
2001-04-30 |
2005-05-10 |
Shire Laboratories, Inc. |
Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancers
|
|
US8088734B2
(en)
|
2003-01-21 |
2012-01-03 |
Unigene Laboratories Inc. |
Oral delivery of peptides
|
|
US20050215476A1
(en)
|
2004-01-21 |
2005-09-29 |
Unigene Laboratories Inc. |
Amidated parathyroid hormone fragments and uses thereof
|
|
US8227241B2
(en)
|
2004-03-12 |
2012-07-24 |
Unigene Laboratories, Inc. |
Bacterial host cell for the direct expression of peptides
|
|
KR20050104152A
(ko)
|
2004-04-28 |
2005-11-02 |
최승호 |
경구용 약물의 흡수를 증진하는 약제학적 조성물
|
|
US20050282756A1
(en)
|
2004-06-18 |
2005-12-22 |
Mehta Nozer M |
Oral delivery of peptide pharmaceutical compositions
|
|
WO2006026592A2
(en)
*
|
2004-08-27 |
2006-03-09 |
Spherics, Inc. |
Oral administration of poorly absorbed drugs, methods and compositions related thereto
|
|
US7445911B2
(en)
|
2004-11-24 |
2008-11-04 |
Unigene Laboratories Inc. |
Enzymatic reactions in the presence of keto acids
|
|
JP4856177B2
(ja)
|
2005-06-24 |
2012-01-18 |
ユニジーン・ラボラトリーズ・インコーポレーテッド |
アミド化生成物の調製に有用な酵素を発現させるための細胞株
|
|
US7449896B2
(en)
*
|
2005-07-29 |
2008-11-11 |
Ixys Corporation |
Current sensor using level shift circuit
|
|
US8093207B2
(en)
|
2005-12-09 |
2012-01-10 |
Unigene Laboratories, Inc. |
Fast-acting oral peptide pharmaceutical products
|
|
EP1964566A4
(en)
*
|
2005-12-22 |
2009-01-07 |
Asubio Pharma Co Ltd |
PREPARATION HAVING IMPROVED BIOABSORPTION CAPACITY OF SAPROPTERIN CHLORHYDRATE
|
|
RU2008121238A
(ru)
*
|
2005-12-22 |
2010-01-27 |
Вайет (Us) |
Способы лечения инфекций желудочно-кишечного тракта с применением тайгециклина
|
|
AR060355A1
(es)
*
|
2007-04-04 |
2008-06-11 |
Kelly Jose Luis |
Aparato para disipar el agua producida por equipos de climatizacion
|
|
US8377863B2
(en)
*
|
2007-05-29 |
2013-02-19 |
Unigene Laboratories Inc. |
Peptide pharmaceutical for oral delivery
|
|
TWI584817B
(zh)
*
|
2007-11-05 |
2017-06-01 |
嘉樂懷醫藥股份有限公司 |
用於增強經口投與之極性劑的生物可用性之調配物
|
|
US20100256060A1
(en)
*
|
2009-04-02 |
2010-10-07 |
Unigene Laboratories Inc. |
Peptide pharmaceuticals for nasal delivery
|
|
US20120071410A1
(en)
|
2010-09-21 |
2012-03-22 |
Unigene Laboratories Inc. |
Calcitonin products and therapies for treating inflammatory or degenerative diseases
|
|
MX377589B
(es)
|
2010-12-16 |
2025-03-10 |
Novo Nordisk As |
Composiciones sólidas que comprenden agonista de glp-1 y sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico.
|
|
AU2012271691A1
(en)
|
2011-06-14 |
2014-01-16 |
Stealth Peptides International, Inc. |
Aromatic-cationic peptides and uses of same
|
|
AU2012271453B2
(en)
|
2011-06-15 |
2017-07-06 |
Resother Pharma Aps |
Anti-inflammatory pharmaceutical products
|
|
WO2014138241A1
(en)
|
2013-03-05 |
2014-09-12 |
Enteris Biopharma, Inc. |
Pharmaceuticals for oral delivery
|
|
US9833411B2
(en)
|
2015-01-12 |
2017-12-05 |
Enteris Biopharma, Inc. |
Solid oral dosage forms
|